News About: Pharm. Industry
Sungkyunkwan University Professor Jae-Hyun Lee becomes first president of K0BD Group
The Korea Drug Research Association(Director Dong-Yeon Kim) held the ‘K-BD Group’ foundation ceremony with 150 experts in the pharmaceutical/biotechnology industry, the academic society, the medical field and in devel...
Kolon Life Science’s ‘Invossa-K’ becomes game changer in osteoarthritis market
After being officially launched on 6 November, Kolon Life Science’s(CEO Woo-Seok Lee) ‘Invossa-K Inj’ has been settled as a new ‘game changer’ through various market activities, such as attracting foreign patients fro...
MOU between KPBMA and KOTRA for Korean pharma’s entry to global markets
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) and the Korea Trade-Investment Promotion Agency(President Jae-Hong Kim, KOTRA) will tighten up their relationship in various fiel...
Will all the credits for biotech & pharmaceutical licenses go to MFDS?
The creation of licenses in the biopharmaceutical field, which was scheduled for enforcement last November, has been stuck in the government agency and association level after the pharmacists’ society.
The Ministry o...
Which drugs MFDS approved the most this year?
This year, the most therapeutic category approved by the Ministry of Food and Drug Safety was anticoagulants with 6 products, and it was followed by 3 products of anticancer drugs and antihypertensives respectively.
...
VP Sun-Ah Kim appointed as Pfizer Essential Health Japan Lead
Pfizer Pharmaceuticals Korea(CEO/President Dong-Wook Oh) announced appointment of Vice President Sun-Ah Kim as Pfizer Essential Health Japan Lead.
VP Sun-Ah Kim, who has managed the Pfizer Essential Health(PEH) APAC ...
Kangstem Biotech acquires approval of world’s first stem cell treatment for atopic dermatitis
Kangstem Biotech(CEO Tae-Hwa Lee) announced on the 5th that it acquired IND(Investigational New Drug) of a Phase III clinical trial for ‘Furestem-AD,’ the world’s first and only stem cell therapeutic product for atopi...
Pfizer Korea & Chong Kun Dang sign distribution agreement of ‘Prevenar’ vaccines for adult
Pfizer Pharmaceuticals Korea(CEO Dong-Wook Oh) and Chong Kun Dang(CEO Young-Joo Kim) announced on the 1st that they signed a Korean distribution agreement of adult products for ‘Prevenar 13 Inj,’ a pneumococcal conjug...
Zemiglo reached deadlock over ‘letter of application’ for marketing data
The LG Chem(former LG Life Sciences) and Sanofi Aventis’s ‘Zemiglo license trial’ have reached a deadlock over a level of turning in data and documents.
While LG Chem argues Sanofi is not providing necessary informat...
Doctors and pharmas tense over stricter regulations for rebates relate to international symposiums
The industry has paid attention to the meetup among authorities to eradicate illegal rebates.
With the government’s will towards the anti-corruptive policy, the Anti-Corruption and Civil Rights Commission(ACRC) sugge...
